"The
Report Ankylosing Spondylitis (Bekhterevs Disease) Global Clinical
Trials Review, H1, 2016 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
Summary
GlobalData's
clinical trial report,
Ankylosing Spondylitis (Bekhterev's Disease) Global
Clinical Trials Review, H1, 2016" provides an overview of
Ankylosing Spondylitis (Bekhterev's Disease) clinical trials
scenario. This report provides top line data relating to the clinical
trials on Ankylosing Spondylitis (Bekhterev's Disease). Report
includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe. The report offers coverage
of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/724089
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and
Withdrawn)
with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
Of Content
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing
to Clinical Trials in Europe 11
Top Countries Contributing to
Clinical Trials in North America 12
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to
Clinical Trials in Central and South America 14
Clinical Trials by G7
Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease)
to Musculoskeletal Disorders Clinical Trials 15
Clinical Trials by Phase in G7
Countries 17
Clinical Trials in G7 Countries
by Trial Status 18
Clinical Trials by E7
Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease)
to Musculoskeletal Disorders Clinical Trials 19
Clinical Trials by Phase in E7
Countries 21
Clinical Trials in E7 Countries
by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status
25
Clinical Trials by End Point
Status 26
Subjects Recruited Over a
Period of Time 27
Clinical Trials by Sponsor Type
28
Prominent Sponsors 29
Top Companies Participating in
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical
Trials 30
Prominent Drugs 32
Latest Clinical Trials News on
Ankylosing Spondylitis (Bekhterev's Disease) 33
Mar 18, 2016: Celltrion
Healthcare: Switching to Remsima (infliximab) from originator has no
negative effect on safety or efficacy in 10 real-world studies 33
Mar 16, 2016: Significantly
higher persistence with SIMPONI (golimumab) in patients with
rheumatic diseases compared with other subcutaneous TNF-alpha
inhibitors, new study reveals 34
Clinical Trial Profile
Snapshots 35
Appendix 216
Abbreviations 216
Definitions 216
Research Methodology 217
Secondary Research 217
About GlobalData 218
Contact Us 218
Disclaimer 218
Source 219
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment